{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibcrsb47no6tbmcm443nmdxgpwouonz473ldyvoavpuwknq6sevxa",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mkp2gryrbso2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiexec4i5xkqm3frvb5mjlrzbinav7ncnaaksc3bzh6hnglwnefn4q"
    },
    "mimeType": "image/jpeg",
    "size": 93233
  },
  "path": "/2026/04/29/rfk-jr-peptides-upcoming-fda-policy-shift-compounding-drugs/?utm_campaign=rss",
  "publishedAt": "2026-04-29T08:30:00.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "First Opinion",
    "Lab Dish",
    "Opinions+",
    "FDA",
    "Policy",
    "RFK Jr.",
    "STAT+"
  ],
  "textContent": "RFK Jr. had long signaled that he was going to do something big on peptides. Now the moment has arrived.",
  "title": "Opinion: STAT+: Did Kennedy just stack the deck on FDA oversight of peptides?",
  "updatedAt": "2026-04-28T22:18:19.000Z"
}